Article Versions Notes

Chang C-F, Chen L-C, Chen Y-T, Huang C-Y, Yu C-C, Lin VC, Lu T-L, Huang S-P, Bao B-Y. Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis. Biomedicines. 2025; 13(1):25. https://doi.org/10.3390/biomedicines13010025

Chang, Chi-Fen, Lih-Chyang Chen, Yei-Tsung Chen, Chao-Yuan Huang, Chia-Cheng Yu, Victor C. Lin, Te-Ling Lu, Shu-Pin Huang, and Bo-Ying Bao. 2025. "Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis" Biomedicines 13, no. 1: 25. https://doi.org/10.3390/biomedicines13010025

Chang, C.-F., Chen, L.-C., Chen, Y.-T., Huang, C.-Y., Yu, C.-C., Lin, V. C., Lu, T.-L., Huang, S.-P., & Bao, B.-Y. (2025). Unveiling DENND2D as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis. Biomedicines, 13(1), 25. https://doi.org/10.3390/biomedicines13010025